Vera Therapeutics, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.17M-0.02M0.91M-1.96M-5.69M
Gross Profit -0.17M-0.02M0.91M-1.96M-5.69M
Operating items
Research & Development 45.21M22.48M68.99M78.22M126.17M
Selling, General & Administrative 4.04M11.92M21.91M23.79M41.00M
Restructuring Costs 3.00M
Other Operating Expenses 2.69M
Operating Expenses 52.24M34.40M90.90M102.01M167.17M
Operating Income -52.24M-34.40M-90.90M-102.01M-167.17M
EBIT -52.24M-34.40M-90.90M-102.01M-167.17M
Non-operating items
Interest & Investment Income 0.01M0.01M1.75M7.98M20.71M
Non Operating Income -1.17M1.79M1.85M6.02M15.02M
Net income details
EBT -53.41M-32.61M-89.06M-95.99M-152.15M
Tax Provisions -0.00M0.00M0.00M0.00M0.00M
Profit After Tax -53.41M-32.61M-89.06M-95.99M-152.15M
Equity Income -0.89M-0.81M-0.05M
Income from Continuing Operations -53.41M-32.61M-89.06M-95.99M-152.15M
Consolidated Net Income -53.41M-32.61M-89.06M-95.99M-152.15M
Income towards Parent Company -53.41M-32.61M-89.06M-95.99M-152.15M
Net Income towards Common Stockholders -53.41M-32.61M-89.06M-95.99M-152.15M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 20.48M27.05M27.66M44.43M63.32M
EBITDA -52.24M-34.40M-89.28M-95.74M-152.01M
Tax Rate 0.00%